Compare SANA & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SANA | TBLD |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.5M | 713.5M |
| IPO Year | 2021 | 2020 |
| Metric | SANA | TBLD |
|---|---|---|
| Price | $2.01 | $20.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.43 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 42.8K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.09% |
| EPS Growth | ★ 17.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $19.48 |
| 52 Week High | $5.49 | $23.02 |
| Indicator | SANA | TBLD |
|---|---|---|
| Relative Strength Index (RSI) | 32.21 | 51.27 |
| Support Level | N/A | $19.80 |
| Resistance Level | $3.41 | $20.80 |
| Average True Range (ATR) | 0.19 | 0.29 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 15.96 | 57.24 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.